Free Trial

WELL Health Technologies (TSE:WELL) Stock Price Down 1.8% - Should You Sell?

WELL Health Technologies logo with Medical background
Image from MarketBeat Media, LLC.

Key Points

  • WELL shares fell 1.8% to C$3.77 on Friday with 1,143,466 shares traded (about 23% below the average), and the stock is trading below its 50‑day (C$4.01) and 200‑day (C$4.28) moving averages.
  • Analysts maintain an overall "Buy" consensus with an average price target of C$7.32 (five Buy ratings); Scotiabank trimmed its target to C$6.50 but kept an "outperform" rating.
  • Recent fundamentals show a C$963M market cap, quarterly revenue of C$384.77M and reported EPS of C$0.20, but the company posts a negative net margin and negative ROE (PE ratio -125.67), signaling continued profitability challenges.
  • Interested in WELL Health Technologies? Here are five stocks we like better.

WELL Health Technologies Corp. (TSE:WELL - Get Free Report) shares fell 1.8% on Friday . The company traded as low as C$3.76 and last traded at C$3.77. 1,143,466 shares changed hands during mid-day trading, a decline of 23% from the average session volume of 1,480,172 shares. The stock had previously closed at C$3.84.

Analyst Upgrades and Downgrades

Separately, Scotiabank cut their price objective on shares of WELL Health Technologies from C$7.00 to C$6.50 and set an "outperform" rating on the stock in a report on Wednesday, February 4th. Five analysts have rated the stock with a Buy rating, According to MarketBeat, the stock currently has an average rating of "Buy" and an average price target of C$7.32.

View Our Latest Stock Report on WELL

WELL Health Technologies Trading Down 1.8%

The stock's fifty day moving average price is C$4.01 and its 200 day moving average price is C$4.28. The company has a quick ratio of 1.02, a current ratio of 1.03 and a debt-to-equity ratio of 82.33. The stock has a market cap of C$963.10 million, a PE ratio of -125.67, a PEG ratio of -1.93 and a beta of 0.94.

WELL Health Technologies (TSE:WELL - Get Free Report) last posted its quarterly earnings results on Thursday, March 19th. The company reported C$0.20 EPS for the quarter. WELL Health Technologies had a negative net margin of 0.53% and a negative return on equity of 0.87%. The firm had revenue of C$384.77 million for the quarter. On average, sell-side analysts forecast that WELL Health Technologies Corp. will post 0.3000698 EPS for the current year.

WELL Health Technologies Company Profile

(Get Free Report)

WELL Health Technologies Corp is the owner and operator of a portfolio of Primary Hclinics delivering healthcare-related services It operates through below segments: clinical operations and allied health, Electronic medical record (EMR), Billing and revenue cycle management solutions, Digital apps, Cybersecurity, CRH, MyHealth, and corporate/shared services. Its segments are grouped in three divisions; Omni-channel Patient Services - Primary includes clinical operations and allied health. Omni-channel Patient Services - Specialized comprises CRH and MyHealth under two segments.

Recommended Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in WELL Health Technologies Right Now?

Before you consider WELL Health Technologies, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and WELL Health Technologies wasn't on the list.

While WELL Health Technologies currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines